Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study
Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study(361 views)(PDF public224 views) Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F, COGIMUS
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2011 Oct 14; 11: 125-125.
National Neurological Institute, C Mondino Foundation, IRCCS, Via Ferrata, I-27100, Pavia, Italy
European Biomedical Foundation Onlus, via Nizza 53, 00198, Rome, Italy
Department of Neurology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
IRCCS Foundazione Santa Lucia, Via Ardeatina 306, 00179 Rome, Italy
Biostructure and Bioimaging Institute, National Research Council, Via Pansini 5, 80131 Naples, Italy
Opera S. r. l., Via Sampierdarena 33, 16149 Genova, Italy
Opera S.r.l., Via Sampierdarena 33, 16149 Genova, Italy
References: McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., McFarland, H. F., Wolinsky, J. S., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis (2001) Ann Neurol, 50, pp. 121-127. , 10. 1002/ana. 1032, 1145630
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial (1993) Neurology, 43, pp. 655-661. , IFNB Multiple Sclerosis Study Group
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Schiffer, R. B., Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial (1995) Neurology, 45, pp. 1268-1276
Li, D. K., Paty, D. W., Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis (1999) Ann Neurol, 46, pp. 197-206. , 10. 1002/1531-8249 (199908) 46: 2<197:: AID-ANA9>
3. 0. CO
2-P, 10443885, UBC MS/MRI Analysis Research Group, PRISMS Study Group
Simon, J. H., Jacobs, L. D., Campion, M., Wende, K., Simonian, N., Cookfair, D. L., Rudick, R. A., Whitham, R. H., Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis (1998) Ann Neurol, 43, pp. 79-87. , 10. 1002/ana. 410430114, 9450771
De Stefano, N., Curtin, F., Stubinski, B., Blevins, G., Drulovic, J., Issard, D., Shotekov, P., Gasperini, C., Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis (2010) Mult Scler, 16, pp. 888-892. , 10. 1177/1352458510362442, 20200197, IMPROVE Study Investigators
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis (1998) Lancet, 352, pp. 1498-1504. , 10. 1016/S0140-6736 (98) 03334-0, 9820297, PRISMS Study Group
Kappos, L., Traboulsee, A., Constantinescu, C., Er linna, J. P., Forrestal, F., Jongen, P., Pollard, J., Li, D., Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS (2006) Neurology, 67, pp. 944-953. , 10. 1212/01. wnl. 0000237994. 95410. ce, 17000959
Barkhof, F., The clinico-radiological paradox in multiple sclerosis revisited (2002) Curr Opin Neurol, 15, pp. 239-245. , 10. 1097/00019052-200206000-00003, 12045719
Zivadinov, R., Leist, T. P., Clinical-magnetic resonance imaging correlations in multiple sclerosis (2005) J Neuroimaging, 15 (4 SUPPL.), pp. 10S-21S
Amato, M. P., Zipoli, V., Portaccio, E., Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies (2006) J Neurol Sci, 245, pp. 41-46. , 10. 1016/j. jns. 2005. 08. 019, 16643953
Glanz, B. I., Healy, B. C., Rintell, D. J., Jaffin, S. K., Bakshi, R., Weiner, H. L., The association between cognitive impairment and quality of life in patients with early multiple sclerosis (2010) J Neurol Sci, 290, pp. 75-79. , 10. 1016/j. jns. 2009. 11. 004, 19944429
Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., Unverzagt, F., Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning (1991) Neurology, 41, pp. 692-696
Lazeron, R. H., de Sonneville, L. M., Scheltens, P., Polman, C. H., Barkhof, F., Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction (2006) Mult Scler, 12, pp. 760-768. , 10. 1177/1352458506070924, 17263004
Rovaris, M., Filippi, M., MRI correlates of cognitive dysfunction in multiple sclerosis patients (2000) J Neurovirol, 6 (SUPPL. 2), pp. S172-S175
Patti, F., Amato, M., Trojano, M., Bastianello, S., Tola, M. R., Goretti, B., Caniatti, L., Luccichenti, G., Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study (2009) Mult Scler, 15, pp. 779-788. , 10. 1177/1352458509105544, 19542262, COGIMUS Study Group
Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Ricchiuti, L., De Caro, M. F., Patti, F., Trojano, M., The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population (2006) Mult Scler, 12, pp. 787-793. , 10. 1177/1352458506070933, 17263008
Colombo, L., Sartori, G., Brivio, C., La stima del quoziente intellettivo tramite l'Applicazione del TIB (Test di Intelligenza Breve) (2002) G Ital Psicol, 3, pp. 613-637
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., Schlech, W. F., Measuring the functional impact of fatigue: initial validation of the fatigue impact scale (1994) Clin Infect Dis, 18 (SUPPL. 1), pp. S79-S83
Hamilton, M., A rating scale for depression (1960) J Neurol Neurosurg Psychiatry, 23, pp. 56-62. , 10. 1136/jnnp. 23. 1. 56, 495331, 14399272
Mellerup, E., Fog, T., Raun, N., Colville, P., De Rham, B., Hannah, B., Kurtzke, J., The socio-economic scale (1981) Acta Neurol Scand, 64, pp. 130-138
Rudick, R. A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P. A., Confavreux, C., Galetta, S. L., Panzara, M. A., Health-related quality of life in multiple sclerosis: effects of natalizumab (2007) Ann Neurol, 62, pp. 335-346. , 10. 1002/ana. 21163, 17696126, AFFIRM and SENTINEL Investigators
Summers, M., Swanton, J., Fernando, K., Dalton, C., Miller, D. H., Cipolotti, L., Ron, M. A., Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease (2008) J Neurol Neurosurg Psychiatry, 79, pp. 955-958. , 10. 1136/jnnp. 2007. 138685, 18339729
Deloire, M. S., Salort, E., Bonnet, M., Arimone, Y., Boudineau, M., Amieva, H., Barroso, B., Brochet, B., Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis (2005) J Neurol Neurosurg Psychiatry, 76, pp. 519-526. , 10. 1136/jnnp. 2004. 045872, 1739602, 15774439
Patti, F., Failla, G., Ciancio, M. R., L'Episcopo, M. R., Reggio, A., Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study (1998) Eur J Neurol, 5, pp. 283-286. , 10. 1046/j. 1468-1331. 1998. 530283. x, 10210843
Rudick, R. A., Lee, J. C., Simon, J., Fisher, E., Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study (2006) Ann Neurol, 60, pp. 236-242. , 10. 1002/ana. 20883, 16786526
Blinkenberg, M., Rune, K., Jensen, C. V., Ravnborg, M., Kyllingsbaek, S., Holm, S., Paulson, O. B., S rensen, P. S., Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS (2000) Neurology, 54, pp. 558-564
Mowry, E. M., Beheshtian, A., Waubant, E., Goodin, D. S., Cree, B. A., Qualley, P., Lincoln, R., Pelletier, D., Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures (2009) Neurology, 72, pp. 1760-1765. , 10. 1212/WNL. 0b013e3181a609f8, 2683738, 19451531
Calabrese, M., Filippi, M., Gallo, P., Cortical lesions in multiple sclerosis (2010) Nat Rev Neurol, 6, pp. 438-444. , 10. 1038/nrneurol. 2010. 93, 20625376
Calabrese, M., Rinaldi, F., Grossi, P., Gallo, P., Cortical pathology and cognitive impairment in multiple sclerosis (2011) Expert Rev Neurother, 11, pp. 425-432. , 10. 1586/ern. 10. 155, 21375447
McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Wolinsky, J.S., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis (2001) Ann Neurol, 50, pp. 121-127. , 10.1002/ana.1032, 1145630
Johnson, K.P., Brooks, B.R., Cohen, J.A., Ford, C.C., Goldstein, J., Lisak, R.P., Myers, L.W., Schiffer, R.B., Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial (1995) Neurology, 45, pp. 1268-1276
Li, D.K., Paty, D.W., Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis (1999) Ann Neurol, 46, pp. 197-206. , 10.1002/1531-8249(199908)46:2<197::AID-ANA9>
3.0.CO
Simon, J.H., Jacobs, L.D., Campion, M., Wende, K., Simonian, N., Cookfair, D.L., Rudick, R.A., Whitham, R.H., Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis (1998) Ann Neurol, 43, pp. 79-87. , 10.1002/ana.410430114, 9450771
Amato, M.P., Zipoli, V., Portaccio, E., Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies (2006) J Neurol Sci, 245, pp. 41-46. , 10.1016/j.jns.2005.08.019, 16643953
Glanz, B.I., Healy, B.C., Rintell, D.J., Jaffin, S.K., Bakshi, R., Weiner, H.L., The association between cognitive impairment and quality of life in patients with early multiple sclerosis (2010) J Neurol Sci, 290, pp. 75-79. , 10.1016/j.jns.2009.11.004, 19944429
Rao, S.M., Leo, G.J., Ellington, L., Nauertz, T., Bernardin, L., Unverzagt, F., Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning (1991) Neurology, 41, pp. 692-696
Lazeron, R.H., de Sonneville, L.M., Scheltens, P., Polman, C.H., Barkhof, F., Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction (2006) Mult Scler, 12, pp. 760-768. , 10.1177/1352458506070924, 17263004
Amato, M.P., Portaccio, E., Goretti, B., Zipoli, V., Ricchiuti, L., De Caro, M.F., Patti, F., Trojano, M., The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population (2006) Mult Scler, 12, pp. 787-793. , 10.1177/1352458506070933, 17263008
Fisk, J.D., Ritvo, P.G., Ross, L., Haase, D.A., Marrie, T.J., Schlech, W.F., Measuring the functional impact of fatigue: initial validation of the fatigue impact scale (1994) Clin Infect Dis, 18 (SUPPL. 1), pp. S79-S83
Rudick, R.A., Miller, D., Hass, S., Hutchinson, M., Calabresi, P.A., Confavreux, C., Galetta, S.L., Panzara, M.A., Health-related quality of life in multiple sclerosis: effects of natalizumab (2007) Ann Neurol, 62, pp. 335-346. , 10.1002/ana.21163, 17696126, AFFIRM and SENTINEL Investigators
Deloire, M.S., Salort, E., Bonnet, M., Arimone, Y., Boudineau, M., Amieva, H., Barroso, B., Brochet, B., Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis (2005) J Neurol Neurosurg Psychiatry, 76, pp. 519-526. , 10.1136/jnnp.2004.045872, 1739602, 15774439
Rudick, R.A., Lee, J.C., Simon, J., Fisher, E., Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study (2006) Ann Neurol, 60, pp. 236-242. , 10.1002/ana.20883, 16786526
Mowry, E.M., Beheshtian, A., Waubant, E., Goodin, D.S., Cree, B.A., Qualley, P., Lincoln, R., Pelletier, D., Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures (2009) Neurology, 72, pp. 1760-1765. , 10.1212/WNL.0b013e3181a609f8, 2683738, 19451531
Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study
Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study
No results.
Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study
Vitiello M, Finamore E, Falanga A, Raieta K, Cantisani M, Galdiero F, Pedone C, Galdiero M, Galdiero S * Fusion in Coq(479 views) Lecture Notes In Computer Science (ISSN: 0302-9743, 0302-974335404636319783540463634, 0302-974335402975459783540297543), 2001; 2178LNCS: 583-596. Impact Factor:0.415 ViewExport to BibTeXExport to EndNote